Delivery Order SPE2DB24D2101-SPE2DB24FKFSY

Award Date 8/7/24
Potential Completion Date 8/8/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The $59,606.40 contract has an ultimate completion date of August 16, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) awarded a $2,561.90 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. This order is for the supply of M-M-R II vaccine vials, with an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,049.52 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of M-M-R II vaccine vials and does not have a set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,706.51 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of M-M-R II vaccine vials and has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $2,049.52 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of M-M-R II vaccine vials. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. The contract has a potential value of $4,450.55 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract worth $5,123.90 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of M-M-R II vaccine vials, a critical medical product, with an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of M-M-R II vaccine vials. The contract has a completion date of February 12, 2024 and a potential value of $9,327.02. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is not set-aside. The contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
This is a $1,458.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of M-M-R II vaccine vials, with a completion date of September 23, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various defense and civilian agencies through its extensive supply chain. The company holds several...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $2,184.03 fixed-price contract is for the supply of M-M-R II vaccine vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment programs...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFSY
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,332.32 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,565,372,780 M-M-R II vaccine vials. This award is not set aside and has an ultimate completion date of August 8, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of medical commodities and prescription drugs to support federal healthcare programs and facilities.

Generated 11/6/24, 9:19 AM